Source: https://www.law.cornell.edu/uscode/text/42/283?quicktabs_8=3
Timestamp: 2016-05-01 22:51:31
Document Index: 593183775

Matched Legal Cases: ['§ 283', '§ 283', '§ 283', '§\u202f403', '§\u202f104', '§\u202f1104', '§\u202f403', '§\u202f2', '§\u202f112', '§\u202f104']

42 U.S. Code § 283 - Biennial reports of Director of NIH | US Law | LII / Legal Information Institute
U.S. Code › Title 42 › Chapter 6A › Subchapter III › Part A › § 283 42 U.S. Code § 283 - Biennial reports of Director of NIH
(a) In generalThe Director of NIH shall submit to the Congress on a biennial basis a report in accordance with this section. The first report shall be submitted not later than 1 year after January 15, 2007. Each such report shall include the following information:
Classification and justification for the priorities established by the agencies, including a strategic plan and recommendations for future research initiatives to be carried out under section 282(b)(7) of this title through the Division of Program Coordination, Planning, and Strategic Initiatives.
(A) The catalog shall, for each such activity—
In the case of clinical research, the catalog shall, as appropriate, identify study populations by demographic variables and other variables that contribute to research on minority health and health disparities.
(iv) Training activities, including—
National Research Service Awards and Clinical Transformation Science Awards;
graduate medical education programs, including information on the number and type of graduate degrees awarded during the period in which the programs received funding under this subchapter;
investigator-initiated awards for postdoctoral training and postdoctoral training funded through research grants;
a breakdown by demographic variables and other appropriate categories; and
an evaluation and comparison of outcomes and effectiveness of various training programs.
Clinical trials, including a breakdown of participation by study populations and demographic variables and such other information as may be necessary to demonstrate compliance with section 289a–2 of this title (regarding inclusion of women and minorities in clinical research).
(6) A review of each entity receiving funding under this subchapter in its capacity as a center of excellence (in this paragraph referred to as a “center of excellence”), including the following:
An evaluation of the performance and research outcomes of each center of excellence.
Recommendations for promoting coordination of information among the centers of excellence.
If no additional centers of excellence have been funded under this subchapter since the previous report under this section, an explanation of the reasons for not funding any additional centers.
(b) Requirement regarding disease-specific research activitiesIn a report under subsection (a), the Director of NIH, when reporting on research activities relating to a specific disease, disorder, or other adverse health condition, shall—
(July 1, 1944, ch. 373, title IV, § 403, as added Pub. L. 109–482, title I, § 104(a)(3), Jan. 15, 2007, 120 Stat. 3689; amended Pub. L. 110–85, title XI, § 1104(3), Sept. 27, 2007, 121 Stat. 975.)
A prior section 283, act July 1, 1944, ch. 373, title IV, § 403, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 826; amended Pub. L. 100–607, title I, § 112, Nov. 4, 1988, 102 Stat. 3052, required a biennial report by the Director to the President and Congress, prior to repeal by Pub. L. 109–482, title I, § 104(a)(3), Jan. 15, 2007, 120 Stat. 3689.
2007—Subsec. (a)(4)(C)(iv)(III). Pub. L. 110–85 inserted “and postdoctoral training funded through research grants” before semicolon at end.